The Year of the Retraction: A look back at 2011

Don Quixote and Sancho Panza, Madrid. Photo by Zaqarbal via Wikimedia

If Retraction Watch was actually a business, as opposed — for the moment, anyway — to a labor of love for two guys with day jobs, 2011 would have been a very good year for business.

It was a year that will probably see close to 400 retractions, including a number of high-profile ones, once the dust settles. Those high numbers caught the attention of a lot of major media outlets, from Nature to NPR to the Wall Street Journal. Science publications, including LiveScience and The Scientist, have done their own end-of-year retraction lists.

It was also a good year for us at Retraction Watch. Many news outlets featured us in their coverage, either picking up stories we’d broken or asking us for comment on big-picture issues. Three national NPR programs — Science Friday, On the Media, and All Things Considered — had us on air. We launched a column in LabTimes, and Nature asked us to write a year-end commentary. We even earned a Wikipedia entry. Continue reading The Year of the Retraction: A look back at 2011

Blood retracts stem cell paper from Amy Wagers’ Harvard lab after 14 months of concern

More than 14 months after Blood issued a notice of concern about a paper by a Harvard stem cell scientist and her former post-doc, the journal has retracted the article.

Here’s the notice for the paper, “Osteolineage niche cells initiate hematopoietic stem cell mobilization,” by Shane Mayack and Amy Wagers: Continue reading Blood retracts stem cell paper from Amy Wagers’ Harvard lab after 14 months of concern

Stop fetishizing the scientific paper: Our invited Comment in Nature

courtesy Nature

If there’s one consistent lesson of covering retractions, it’s that science doesn’t stop when researchers publish a paper. But what also seems true is that once a paper is published, lots of people — authors and editors, in particular — are often reluctant to say just what’s happened next, particularly if it casts the study or the journal in a negative light.

Some of this is understandable, given the weight given papers by tenure committees and granting agencies. Still, Retraction Watch readers will not be surprised to know we’d like that to change, so when Nature asked us to contribute an end-of-the-year commentary, we decided to focus on post-publication peer review. In our piece, which appears this week, titled “The paper is not sacred,” we argue: Continue reading Stop fetishizing the scientific paper: Our invited Comment in Nature

Another Hattori retraction over reused figure from cardiology pub

Another paper in Diabetologia by Yoshiyuki Hattori has been retracted for image duplication, marking the second of his articles in the journal to be pulled for that reason.

The notice for the article, “A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells,” states: Continue reading Another Hattori retraction over reused figure from cardiology pub

Cardiff University misconduct investigation leads to Journal of Immunology retraction

The senior author of a Journal of Immunology paper has retracted it after a university investigation found that he had inappropriately manipulated images, Retraction Watch has learned.

Here’s the notice: Continue reading Cardiff University misconduct investigation leads to Journal of Immunology retraction

Which came first? Vet journal retracts previously published chicken paper

Research in Veterinary Science has retracted a 2010 paper by Egyptian scientists who published the same article the previous year in a different journal.

Here’s the retraction notice for the paper, “Comparative biochemical studies on steroidogenic compounds in chickens,” by Mohamed O.T. Badr and Mohamed A. Hashem,  from Zagazig University and the Egyptian Ministry of Agriculture: Continue reading Which came first? Vet journal retracts previously published chicken paper

Duplication earns German HIV researchers a retraction, and a 3-year publishing ban

An HIV researcher in Germany has run afoul of a number of journals because he duplicated his papers in multiple outlets.

The funny business by Ulrich Hengge earned him a 3-year ban on publishing in two journals, the Journal of Molecular Medicine (JMM) and Cells, Tissues and Organs (CTO). (We’ve written about publishing bans — which appear to be fairly rare — before.)

Those journals also sanctioned one of his co-authors, Alireza Mirmohammadsadegh. The JMM’s managing editor, Christiane Nolte, told us by email: Continue reading Duplication earns German HIV researchers a retraction, and a 3-year publishing ban

PNAS retracts two papers on osmolytes after researchers discover crucial measurement errors

A good carpenter never blames his tools. But for scientists, sometimes machines do go bad–with disastrous results. Consider the following:

The Proceedings of the National Academy of Sciences has retracted two papers by researchers in the United Kingdom and the United States after the scientists learned that their results were based largely on a problem with their highly sensitive instruments.

Continue reading PNAS retracts two papers on osmolytes after researchers discover crucial measurement errors

Heart study pulled after production glitch leads to duplicate publication

On reflection, that headline pretty much says it all. But for those readers who took the time to click on the link, here’s the rest of it.

The journal Heart, a title of the BMJ group, has retracted a paper that it published twice: Continue reading Heart study pulled after production glitch leads to duplicate publication

Bulfone-Paus retraction count grows to 13 with one in Transplantation

Silvia Bulfone-Paus, the Borstel Institute researcher who was forced to step down as institute director and has already retracted 12 papers, has retracted another, this one in Transplantation. Here’s the text of the notice: Continue reading Bulfone-Paus retraction count grows to 13 with one in Transplantation